Contact Us: (888) 783-5280 |

QRDA3 Generator


ReportingMD’s unique Quality Data Model (QDM) and QRDA3 Generator are embedded within the Total Outcomes Management (TOM™) application. TOM™ is ONC Certified for data collection, translation, aggregation, and submission of electronic Clinical Quality Measures (eCQMs). This powerful engine can take EHR data, QRDA1 files, CCD files, and other HL7 files and convert them to the QRDA3 file format. ReportingMD’s current system is certified based on the 2015 ONC specifications and therefore supports data aggregation accurately through the 2019 reporting year.

2015 Certified Product Information

Product Name: Total Outcomes Management (TOM™)
Product Version: 9.7
Certification Number:
Certification Date: 2019-12-23
Criteria Certified: 170.315(c): (c)(2)(c)(3), 170.315(d): (d)(1)(d)(2)(d)(3)(d)(5), 170.315(g): (g)(4)(g)(5)
CQM Certified: CMS 56 V7
CMS 66 V7
CMS 69 V7
CMS 122 V7
CMS 124 V7
CMS 125 V7
CMS 127 V7
CMS 130 V7
CMS 138 V7
CMS 139 V7
CMS 147 V8
CMS 165 V7

2014 Certified Product Information

Product Name: Total Outcomes Management (TOM)
Product Version: 9
Certification Number: IG-3350-15-0069
Certification Date: December 22, 2015
Criteria Certified: 314(c) (1)-(3) and 314(g)(4)
CQM Certified: CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS56: Functional Status Assessment for Total Hip Replacement
CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed
CMS62: HIV/AIDS: Medical Visit
CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75: Children Who Have Dental Decay or Cavities
CMS77: HIV/AIDS: RNA control for Patients with HIV
CMS82: Maternal Depression Screening
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS117: Childhood Immunization Status
CMS122: Diabetes: Hemoglobin A1c Poor Control
CMS123: Diabetes: Foot Exam
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS126: Use of Appropriate Medications for Asthma
CMS127: Pneumonia Vaccination Status for Older Adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130: Colorectal Cancer Screening
CMS131: Diabetes: Eye Exam
CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134: Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136: ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer
CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients
CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS148: Hemoglobin A1c Test for Pediatric Patients
CMS149: Dementia: Cognitive Assessment
CMS153: Chlamydia Screening for Women
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156: Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS158: Pregnant women that had HBsAg testing
CMS159: Depression Remission at Twelve Months
CMS160: Depression Utilization of the PHQ-9 Tool
CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS163: Diabetes: Low Density Lipoprotein (LDL) Management
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain
CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range
CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control


Total Outcomes Management (TOM™) is 2014 and 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Additional Types of Costs

Outside of standard license agreement, there are no additional types of costs or fees (whether fixed, recurring, transaction-based, or otherwise) imposed by ReportingMD to purchase, license, implement, maintain, upgrade, use, or otherwise enable and support the use of capabilities to which TOM™ is certified; or in connection with any data generated in the course of using any capability to which TOM™ is certified.

Contractual / Business Practices Limitations

ReportingMD imposes no limitations, whether by contract or otherwise, on the use of any capability to which technology is certified for any purpose within the scope of the technology’s certification; or in connection with any data generated in the course of using any capability to which TOM™ is certified.

Technical / Practical Limitations

ReportingMD imposes no limitations, including but not limited to technical or practical limitations of technology or its capabilities, that could prevent or impair the successful implementation, configuration, customization, maintenance, support, or use of any capabilities to which technology is certified; or that could prevent or limit the use, exchange, or portability of any data generated in the course of using any capability to which TOM™ is certified.